Skip to main content

Find Clinical Trials

Home
Conditions
Splenic Marginal Zone Lymphoma

Clinical trial condition

Splenic Marginal Zone Lymphoma

Explore clinical trials studying Splenic Marginal Zone Lymphoma. Study availability and eligibility vary by location and protocol.

98 public trials 3 recruiting studies

Refine in advanced search Browse all conditions

Splenic Marginal Zone Lymphoma trial results

Completed

Palifermin in Preventing Chronic Graft-Versus-Host Disease in Patients Who Have Undergone Donor Stem Cell Transplant for Hematologic Cancer

NCT01233921

Conditions: Accelerated Phase Chronic Myelogenous Leukemia, Adult Acute Lymphoblastic Leukemia in Remission, Adult Acute Myeloid Leukemia With 11q23 (MLL) Abnormalities, +151 more
Locations: Fred Hutchinson Cancer Research Center/University of Washington Cancer Consortium Seattle, Washington, United States

View Trial Details

Completed

Vorinostat in Treating Patients With Metastatic or Unresectable Solid Tumors or Lymphoma and Liver Dysfunction

NCT00499811

Conditions: Adult Grade III Lymphomatoid Granulomatosis, Adult Nasal Type Extranodal NK/T-cell Lymphoma, Anaplastic Large Cell Lymphoma, +112 more
Locations: City of Hope Medical Center Duarte, California, United States

University of Southern California Los Angeles, California, United States

Emory University/Winship Cancer Institute Atlanta, Georgia, United States

National Institutes of Health Bethesda, Maryland, United States

View Trial Details

Completed

Bevacizumab and Cediranib Maleate in Treating Patients With Metastatic or Unresectable Solid Tumor, Lymphoma, Intracranial Glioblastoma, Gliosarcoma or Anaplastic Astrocytoma

NCT00458731

Conditions: Adult Grade III Lymphomatoid Granulomatosis, Adult Nasal Type Extranodal NK/T-cell Lymphoma, Anaplastic Large Cell Lymphoma, +116 more
Locations: M D Anderson Cancer Center Houston, Texas, United States

View Trial Details

Completed

FAU in Treating Patients With Advanced Solid Tumors or Lymphoma

NCT00769288

Conditions: Adult Grade III Lymphomatoid Granulomatosis, Adult Nasal Type Extranodal NK/T-cell Lymphoma, Anaplastic Large Cell Lymphoma, +107 more
Locations: Wayne State University Detroit, Michigan, United States

View Trial Details

Completed

Bortezomib and Fludarabine With or Without Rituximab in Treating Patients With Relapsed or Refractory Indolent Non-Hodgkin's Lymphoma or Chronic Lymphocytic Leukemia

NCT00068315

Conditions: Blood Protein Disorders, Cardiovascular Diseases, Chronic Disease, +41 more
Locations: Mercy Medical Center Canton, Ohio, United States

Case Western Reserve University Cleveland, Ohio, United States

Seidman Cancer Center at University Hospitals Case Medical Center, Case Comprehensive Cancer Center Cleveland, Ohio, United States

Southwest General Health Center Ireland Cancer Center Middleburg Heights, Ohio, United States

View Trial Details

Completed

3-AP and Gemcitabine in Treating Patients With Advanced Solid Tumors or Lymphoma

NCT00293345

Conditions: Anaplastic Large Cell Lymphoma, Angioimmunoblastic T-cell Lymphoma, Blood Protein Disorders, +107 more
Locations: Ohio State University Medical Center Columbus, Ohio, United States

View Trial Details

Completed

Rituximab and Interleukin-12 in Treating Patients With B-Cell Non-Hodgkin's Lymphoma

NCT00026182

Conditions: Chronic Disease, Disease Attributes, Extranodal Marginal Zone B-cell Lymphoma of Mucosa-associated Lymphoid Tissue, +26 more
Locations: North Central Cancer Treatment Group Rochester, Minnesota, United States

View Trial Details

Completed

Rituximab Plus Interleukin-2 in Treating Patients With Hematologic Cancer

NCT00010192

Conditions: B-cell Adult Acute Lymphoblastic Leukemia, Burkitt Lymphoma, Chronic Disease, +82 more
Locations: Ohio State University Medical Center Columbus, Ohio, United States

View Trial Details

Completed

Alvocidib, Fludarabine Phosphate, and Rituximab in Treating Patients With Lymphoproliferative Disorders or Mantle Cell Lymphoma

NCT00058227

Conditions: B-cell Chronic Lymphocytic Leukemia, Blood Protein Disorders, Cardiovascular Diseases, +71 more
Locations: Ohio State University Medical Center Columbus, Ohio, United States

View Trial Details

Completed

Monoclonal Antibody Therapy in Treating Patients With Chronic Lymphocytic Leukemia, Lymphocytic Lymphoma, Acute Lymphoblastic Leukemia, or Acute Myeloid Leukemia

NCT00017472

Conditions: Chronic Disease, Disease Attributes, Extranodal Marginal Zone B-cell Lymphoma of Mucosa-associated Lymphoid Tissue, +34 more
Locations: Ohio State University Medical Center Columbus, Ohio, United States

View Trial Details